Further more, some studies have found that the sensitivity of MDK for the diagnosis of HCC could reach 85% through meta-analysis (Zhang et al., 2019), and other studies have shown that the sensitivity can reach more than 80% in the early stages of liver cancer and AFP-negative liver cancer (Luo et al., 2020). This evidence concerns the gene AFP and liver cancer.